Canada -
Tiếng Anh -
Health Canada
epoprostenol for injection powder for solution
sandoz canada incorporated - epoprostenol (epoprostenol sodium) - powder for solution - 0.5mg - epoprostenol (epoprostenol sodium) 0.5mg - vasodilating agents
Canada -
Tiếng Anh -
Health Canada
epoprostenol for injection powder for solution
sandoz canada incorporated - epoprostenol (epoprostenol sodium) - powder for solution - 1.5mg - epoprostenol (epoprostenol sodium) 1.5mg - vasodilating agents
Úc -
Tiếng Anh -
Department of Health (Therapeutic Goods Administration)
epoprostenol myx epoprostenol (as sodium) 1.5 mg powder for injection vial with diluent vial
mayne pharma international pty ltd - epoprostenol sodium -
Úc -
Tiếng Anh -
Department of Health (Therapeutic Goods Administration)
epoprostenol myx epoprostenol (as sodium) 500 microgram powder for injection vial with diluent vial
mayne pharma international pty ltd - epoprostenol sodium -
Úc -
Tiếng Anh -
Department of Health (Therapeutic Goods Administration)
flolan epoprostenol sodium 1.5 mg powder for injection vial
glaxosmithkline australia pty ltd - epoprostenol sodium -
Úc -
Tiếng Anh -
Department of Health (Therapeutic Goods Administration)
flolan epoprostenol sodium 500 microgram powder for injection vial
glaxosmithkline australia pty ltd - epoprostenol sodium -
Israel -
Tiếng Anh -
Ministry of Health
flolan infusion of epoprostenol 1500 mcg
glaxo smith kline (israel) ltd - epoprostenol as sodium - powder for solution for infusion - epoprostenol as sodium 1.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the treatment of pulmonary arterial hypertension (pah) (idiopathic or heritable pah and pah associated with connective tissue diseases) in patients with who functional class iii-iv symptoms to improve exercise capacity
Israel -
Tiếng Anh -
Ministry of Health
flolan infusion of epoprostenol 500 mcg
glaxo smith kline (israel) ltd - epoprostenol as sodium - powder for solution for infusion - epoprostenol as sodium 0.5 mg/vial - epoprostenol - epoprostenol - flolan is indicated for the treatment of pulmonary arterial hypertension (pah) (idiopathic or heritable pah and pah associated with connective tissue diseases) in patients with who functional class iii-iv symptoms to improve exercise capacity
Vương quốc Anh -
Tiếng Anh -
MHRA (Medicines & Healthcare Products Regulatory Agency)
epoprostenol 500microgram powder and solvent (ph10.5) for solution for infusion vials
ph10.5) for solution for infusion vials (sandoz ltd - epoprostenol sodium - powder and solvent for solution for infusion - 500microgram
Vương quốc Anh -
Tiếng Anh -
MHRA (Medicines & Healthcare Products Regulatory Agency)
epoprostenol 1.5mg powder and solvent (ph10.5) for solution for infusion vials
ph10.5) for solution for infusion vials (sandoz ltd - epoprostenol sodium - powder and solvent for solution for infusion - 1.5mg